Every listed Healthcare company on the NSE, with price, valuation and returns.
ATS tracks 155 listed Healthcare companies with a combined market capitalisation of ₹32.22 lakh crore. The largest by market cap are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. On 7 October 2026, 40 advanced and 65 declined. The median P/E across the 105 companies with a reported P/E is 40.6.
Prices as of 7 October 2026. Market cap in ₹ crore.
| Company | Price (₹) | 1D | Market cap | P/E | P/B | ROE | 1Y | Pages |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,773.60 | -1.69% | 4,25,546 | 35.2 | 5.09 | 14.7% | +12.5% | Results · Shareholding |
| Divi's Laboratories | 9,586.00 | +0.38% | 2,54,478 | 87.0 | 15.18 | 16.2% | +12.5% | Results · Shareholding |
| Torrent Pharmaceuticals | 4,693.90 | -1.64% | 1,58,863 | 72.8 | 18.94 | 27.1% | +12.5% | Results · Shareholding |
| Zydus Lifesciences | 1,151.30 | -0.71% | 1,15,848 | 25.7 | 4.27 | 19.7% | +12.5% | Results · Shareholding |
| Apollo Hospitals Enterprise | 7,884.00 | -0.39% | 1,13,360 | 54.3 | 11.96 | 22.0% | +12.5% | Results · Shareholding |
| Laurus Labs | 2,052.90 | +0.14% | 1,10,827 | 101.4 | 20.91 | 18.2% | +12.5% | Results · Shareholding |
| Cipla | 1,333.00 | -0.54% | 1,07,677 | 32.0 | 3.13 | 11.8% | +12.5% | Results · Shareholding |
| Mankind Pharma | 2,496.00 | -0.16% | 1,03,042 | 50.4 | 6.32 | 12.5% | +12.5% | Results · Shareholding |
| Dr. Reddy's Laboratories | 1,194.90 | -1.08% | 99,533 | 30.1 | 2.60 | 12.1% | +12.5% | Results · Shareholding |
| Aurobindo Pharma | 1,677.90 | -0.88% | 97,453 | 26.3 | 2.57 | 9.9% | +12.5% | Results · Shareholding |
| Lupin | 2,006.70 | -1.11% | 91,742 | 16.6 | 4.09 | 26.9% | +12.5% | Results · Shareholding |
| Max Healthcare Institute | 905.70 | +0.35% | 88,137 | 60.5 | 8.20 | 14.3% | +12.5% | Results · Shareholding |
| Glenmark Pharmaceuticals | 2,286.10 | -1.08% | 64,514 | 35.9 | 6.14 | 14.1% | +12.5% | Results · Shareholding |
| Alkem Laboratories | 5,343.00 | +0.96% | 63,884 | 29.6 | 4.62 | 17.8% | +12.5% | Results · Shareholding |
| Fortis Healthcare | 780.65 | +2.18% | 58,936 | 56.2 | 5.96 | 11.1% | +12.5% | Results · Shareholding |
| Biocon | 360.10 | -2.44% | 58,318 | 117.7 | 1.71 | 1.4% | +12.5% | Results · Shareholding |
| Abbott India | 26,075.00 | -0.15% | 55,408 | 34.3 | 11.61 | 34.5% | +12.5% | Results · Shareholding |
| Gland Pharma | 3,156.20 | +4.99% | 52,000 | 46.1 | 5.02 | 10.5% | +12.5% | Results · Shareholding |
| Anthem Biosciences | 885.95 | -0.49% | 49,765 | 86.4 | 16.36 | 21.7% | +12.5% | Results · Shareholding |
| IPCA Laboratories | 1,938.20 | -0.38% | 49,173 | 37.5 | 6.10 | 15.2% | +12.5% | Results · Shareholding |
| GlaxoSmithKline Pharmaceuticals | 2,645.80 | -3.96% | 44,821 | 42.0 | 19.77 | 49.1% | +12.5% | |
| Ajanta Pharma | 3,575.70 | +0.06% | 44,673 | 39.4 | 9.87 | 25.4% | +12.5% | |
| Emcure Pharmaceuticals | 1,915.30 | -0.37% | 36,312 | 35.9 | 7.34 | 19.7% | +12.5% | |
| Aster DM Quality Care | 680.55 | -0.61% | 35,180 | 110.4 | 7.69 | 9.7% | +12.5% | |
| Narayana Hrudayalaya | 1,731.40 | +0.44% | 35,165 | 43.1 | 7.75 | 19.7% | +12.5% | |
| Wockhardt | 2,163.10 | -0.61% | 35,149 | 85.9 | 7.12 | 4.6% | +12.5% | |
| Global Health | 1,292.50 | -0.64% | 34,721 | 62.4 | 8.76 | 15.2% | +12.5% | |
| Sai Life Sciences | 1,566.00 | +0.51% | 33,165 | 91.7 | 13.35 | 15.1% | +12.5% | |
| Dr. Lal Path Labs | 1,950.50 | -0.70% | 32,569 | 60.1 | 12.99 | 21.6% | +12.5% | |
| Neuland Laboratories | 21,860.00 | -0.21% | 28,046 | 56.3 | 14.96 | 21.4% | +12.5% | |
| Krishna Institute of Medical Sciences | 694.40 | +0.14% | 27,786 | 136.0 | 12.36 | 11.0% | +12.5% | |
| Piramal Pharma | 202.63 | +1.05% | 26,843 | 22.5 | 3.29 | -4.0% | +12.5% | |
| Acutaas Chemicals | 3,159.40 | +0.09% | 25,866 | 67.0 | 15.64 | 24.1% | +12.5% | |
| Rubicon Research | 1,562.20 | -2.17% | 25,737 | 22.5 | 19.97 | 16.4% | +12.5% | |
| Shilpa Medicare | 1,076.90 | +0.30% | 21,062 | 70.8 | 8.13 | 9.8% | +12.5% | |
| Granules India | 845.35 | +1.07% | 20,948 | 31.6 | 4.12 | 13.5% | +12.5% | |
| Caplin Point Laboratories | 2,674.70 | -0.19% | 20,331 | 30.6 | 5.67 | 19.9% | +12.5% | |
| Onesource Specialty Pharma | 1,517.60 | -1.19% | 17,395 | 22.5 | 2.98 | -1.3% | +12.5% | |
| Cohance Lifesciences | 454.40 | -0.57% | 17,384 | 163.6 | 4.44 | 4.7% | +12.5% | |
| Alivus Life Sciences | 1,372.50 | -0.83% | 16,846 | 27.9 | 5.06 | 18.4% | +12.5% | |
| Poly Medicure | 1,625.00 | -0.54% | 16,471 | 52.5 | 5.30 | 11.3% | +12.5% | |
| Alembic Pharmaceuticals | 833.90 | -0.04% | 16,391 | 23.6 | 2.89 | 12.4% | +12.5% | |
| Eris Lifesciences | 1,150.30 | -2.90% | 15,937 | 24.8 | 4.08 | 18.3% | +12.5% | |
| Jubilant Pharmova | 973.40 | -1.60% | 15,417 | 43.8 | 2.17 | 6.0% | +12.5% | |
| Dr. Agarwal's Health Care | 484.05 | -0.58% | 15,335 | 103.4 | 7.57 | 6.8% | +12.5% | |
| Vijaya Diagnostic Centre | 1,475.00 | +0.57% | 15,177 | 81.0 | 15.86 | 19.7% | +12.5% | |
| Artemis Medicare Services | 318.70 | +0.11% | 15,000 | 22.5 | 3.20 | 11.4% | +12.5% | |
| AstraZeneca Pharma India | 5,923.00 | -0.96% | 14,808 | 87.3 | 16.97 | 22.8% | +12.5% | |
| Marksans Pharma | 325.20 | +0.25% | 14,737 | 28.5 | 4.87 | 15.2% | +12.5% | |
| Indegene | 606.00 | +1.63% | 14,576 | 36.4 | 4.64 | 13.9% | +12.5% | |
| Natco Pharma | 811.60 | -1.46% | 14,537 | 12.7 | 1.58 | 16.9% | +12.5% | |
| Syngene International | 360.10 | -0.85% | 14,468 | 65.5 | 2.99 | 6.6% | +12.5% | |
| Concord Biotech | 1,358.80 | -0.73% | 14,215 | 52.0 | 7.05 | 13.6% | +12.5% | |
| Rainbow Childrens Medicare | 1,250.20 | +0.85% | 12,682 | 44.4 | 7.70 | 17.9% | +12.5% | |
| Akums Drugs and Pharmaceuticals | 824.90 | +1.26% | 12,629 | 43.3 | 3.81 | 8.0% | +12.5% | |
| CORONA Remedies | 2,044.10 | +0.28% | 12,502 | 67.5 | 16.74 | 27.4% | +12.5% | |
| Park Medi World | 272.05 | -1.02% | 11,751 | 42.2 | 5.81 | 16.8% | +12.5% | |
| Metropolis Healthcare | 545.00 | -1.38% | 11,299 | 56.0 | 7.47 | 13.4% | +12.5% | |
| Viyash Scientific | 241.18 | +3.41% | 10,526 | 61.5 | 3.62 | 6.6% | +12.5% | |
| Strides Pharma Science | 1,100.50 | +1.08% | 10,144 | 16.5 | 3.26 | 19.7% | +12.5% | |
| Yatharth Hospital & Trauma Care Services | 1,039.10 | -1.86% | 10,012 | 55.3 | 5.62 | 10.4% | +12.5% | |
| Healthcare Global Enterprises | 663.10 | -2.56% | 9,900 | 434.6 | 7.43 | 1.2% | +12.5% | |
| Blue Jet Healthcare | 542.30 | +0.77% | 9,407 | 40.1 | 6.92 | 19.9% | +12.5% | |
| Procter & Gamble Health | 5,221.50 | -1.59% | 8,667 | 24.3 | 16.52 | 61.5% | +12.5% | |
| Aarti Pharmalabs | 955.05 | -2.05% | 8,658 | 40.6 | 4.08 | 8.5% | +12.5% | |
| Thyrocare Technologies | 516.55 | -2.50% | 8,222 | 46.6 | 14.04 | 28.8% | +12.5% | |
| Suven Life Sciences | 307.05 | -0.68% | 8,098 | 22.5 | 13.69 | -78.8% | +12.5% | |
| Bliss GVS Pharma | 682.00 | +0.82% | 7,215 | 53.0 | 6.05 | 11.5% | +12.5% | |
| Supriya Lifescience | 892.35 | -2.51% | 7,182 | 36.2 | 6.00 | 19.1% | +12.5% | |
| Nephrocare Health Services | 643.15 | +1.36% | 6,453 | 75.8 | 5.78 | 9.0% | +12.5% | |
| Senores Pharmaceuticals | 1,390.00 | +0.10% | 6,401 | 50.7 | 3.20 | 16.4% | +12.5% | |
| Sun Pharma Advanced Research Company | 195.51 | -0.70% | 6,345 | 4.0 | 4.74 | 276.9% | +12.5% | |
| FDC | 328.55 | -1.53% | 5,349 | 18.3 | 2.15 | 11.8% | +12.5% | |
| Gufic Biosciences | 422.55 | -1.23% | 4,237 | 57.7 | 6.37 | 10.1% | +12.5% | |
| Gujarat Themis Biosyn | 379.50 | -2.69% | 4,135 | 84.9 | 14.37 | 17.4% | +12.5% | |
| Aarti Drugs | 416.75 | -2.81% | 3,804 | 19.9 | 2.46 | 13.4% | +12.5% | |
| Advanced Enzyme Technologies | 271.70 | -0.51% | 3,041 | 18.3 | 1.86 | 11.1% | +12.5% | |
| Dr Agarwals Eye Hospital | 5,210.50 | +0.30% | 2,518 | 33.0 | 7.27 | 25.2% | +12.5% | |
| Fredun Pharmaceuticals | 1,473.90 | +4.78% | 2,420 | 55.2 | 8.59 | 15.4% | +12.5% | |
| Dishman Carbogen Amcis | 152.50 | -0.70% | 2,391 | 24.5 | 0.36 | 1.6% | +12.5% | |
| Fischer Medical Ventures | 32.63 | -1.54% | 2,136 | 68.6 | 5.56 | 8.6% | +12.5% | |
| Fermenta Biotech | 565.30 | -0.73% | 1,621 | 26.8 | 3.99 | 18.7% | +12.5% | |
| Amrutanjan Health Care | 524.00 | +0.06% | 1,514 | 28.1 | 4.09 | 16.6% | +12.5% | |
| Anlon Healthcare | 28.18 | -4.99% | 1,498 | 47.4 | 3.20 | 16.4% | +12.5% | |
| Gujarat Kidney And Super Speciality | 187.12 | -3.36% | 1,475 | 93.2 | 3.20 | 16.4% | +12.5% | |
| 3B Blackbio Dx | 1,640.70 | +4.16% | 1,408 | 25.4 | 4.34 | 20.2% | +12.5% | |
| Bharat Parenterals | 1,883.10 | +2.54% | 1,298 | 22.5 | 3.20 | 16.4% | +12.5% | |
| GPT Healthcare | 146.34 | -1.13% | 1,201 | 25.4 | 4.46 | 16.3% | +12.5% | |
| Bajaj Healthcare | 323.15 | +0.02% | 1,088 | 47.2 | 2.04 | 3.2% | +12.5% | |
| Bafna Pharmaceuticals | 401.85 | +1.99% | 951 | 122.1 | 9.89 | 12.3% | +12.5% | |
| Health X Platform | 284.15 | -0.28% | 904 | 22.5 | 1.41 | 0.2% | +12.5% | |
| Anuh Pharma | 85.72 | -2.11% | 859 | 19.5 | 2.44 | 12.1% | +12.5% | |
| Amanta Healthcare | 207.56 | +5.00% | 806 | 54.9 | 3.20 | 16.4% | +12.5% | |
| Gaudium IVF and Women Health | 107.50 | -1.63% | 782 | 33.7 | 3.20 | 16.4% | +12.5% | |
| Fabtech Technologies | 143.03 | +1.41% | 636 | 13.1 | 3.20 | 16.4% | +12.5% | |
| HALEOS LABS | 1,584.70 | -0.20% | 479 | 30.3 | 2.24 | 8.4% | +12.5% | |
| Albert David | 810.00 | -3.47% | 462 | 20.5 | 1.18 | -0.4% | +12.5% | |
| Ambalal Sarabhai Enterprises | 40.47 | +4.98% | 310 | 23.9 | 1.96 | 11.9% | +12.5% | |
| Aarey Drugs & Pharmaceuticals | 108.50 | +0.60% | 309 | 74.0 | 2.05 | 2.8% | +12.5% | |
| Bilcare | 94.75 | +1.99% | 223 | 28.8 | 1.13 | 0.8% | +12.5% | |
| Brooks Laboratories | 58.90 | -1.27% | 174 | 13.1 | 1.41 | 22.3% | +12.5% | |
| Bal Pharma | 97.90 | -3.51% | 156 | 21.6 | 1.90 | 7.9% | +12.5% | |
| Alpa Laboratories | 58.10 | -1.07% | 122 | 27.9 | 0.66 | 8.4% | +12.5% | |
| Biofil Chemicals & Pharmaceuticals | 30.54 | +1.43% | 49.7 | 102.7 | 2.30 | 13.8% | +12.5% | |
| GKB Ophthalmics | 61.50 | -0.42% | 31 | 9.6 | 0.59 | 2.3% | +12.5% | |
| 2,057.20 | — | — | — | — | — | — | ||
| 215.72 | — | — | — | — | — | — | ||
| 231.30 | — | — | — | — | — | — | ||
| 330.00 | — | — | — | — | — | — | ||
| 353.85 | — | — | — | — | — | — | ||
| 1,114.50 | — | — | — | — | — | — | ||
| 204.27 | — | — | — | — | — | — | ||
| 227.25 | — | — | — | — | — | — | ||
| 253.95 | — | — | — | — | — | — | ||
| 249.19 | — | — | — | — | — | — | ||
| 251.45 | — | — | — | — | — | — | ||
| 56.73 | — | — | — | — | — | — | ||
| 530.00 | — | — | — | — | — | — | ||
| 196.00 | — | — | — | — | — | — | ||
| 562.75 | — | — | — | — | — | — | ||
| 74.01 | — | — | — | — | — | — | ||
| 32.00 | — | — | — | — | — | — | ||
| 154.03 | — | — | — | — | — | — | ||
| 298.20 | — | — | — | — | — | — | ||
| 304.80 | — | — | — | — | — | — | ||
| 131.69 | — | — | — | — | — | — | ||
| 10.33 | — | — | — | — | — | — | ||
| 2,932.10 | — | — | — | — | — | — | ||
| 972.65 | — | — | — | — | — | — | ||
| 14.58 | — | — | — | — | — | — | ||
| 346.50 | — | — | — | — | — | — | ||
| 117.75 | — | — | — | — | — | — | ||
| 3,809.20 | — | — | — | — | — | — | ||
| 2,712.70 | — | — | — | — | — | — | ||
| 995.00 | — | — | — | — | — | — | ||
| 2,939.90 | — | — | — | — | — | — | ||
| 3,552.20 | — | — | — | — | — | — | ||
| 28.52 | — | — | — | — | — | — | ||
| 449.85 | — | — | — | — | — | — | ||
| 647.70 | — | — | — | — | — | — | ||
| 312.05 | — | — | — | — | — | — | ||
| 23.22 | — | — | — | — | — | — | ||
| 322.65 | — | — | — | — | — | — | ||
| 109.83 | — | — | — | — | — | — | ||
| 1,009.30 | — | — | — | — | — | — | ||
| 520.95 | — | — | — | — | — | — | ||
| 468.45 | — | — | — | — | — | — | ||
| 8.14 | — | — | — | — | — | — | ||
| 120.94 | — | — | — | — | — | — | ||
| 1,619.60 | — | — | — | — | — | — | ||
| 538.50 | — | — | — | — | — | — | ||
| 194.38 | — | — | — | — | — | — | ||
| 951.50 | — | — | — | — | — | — | ||
| 141.25 | — | — | — | — | — | — | ||
| 1,325.90 | — | — | — | — | — | — |
Sector index: Nifty Pharma index
This page lists 155 Healthcare companies with a share price page on ATS, classified by the industry they report to the exchanges.
The median price-to-earnings ratio across the 105 Healthcare companies with a reported P/E is 40.6, based on prices as of 7 October 2026. Companies with negative earnings are excluded from the median.
Amanta Healthcare rose the most (+5.00%) and Anlon Healthcare fell the most (-4.99%) among the Healthcare stocks listed here.
Open a free Demat account with ATS in minutes and start trading the same calls our analysts publish — with India's lowest brokerage and 24×7 support.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities quoted are for illustration only and are not recommendatory. Past performance of any analyst recommendation is not indicative of future returns.
ATS Share Brokers Pvt Ltd — SEBI Registration No. INZ000205136 · NSE Member ID: 13840 · BSE Member ID: 6481 · MCX Member ID: 10795 · NCDEX Member ID: 00278. For full terms, conflict-of-interest disclosures and grievance redressal information visit adityatrading.in.